David Erritzoe is Clinical Senior Lecturer and Consultant Psychiatrist at Imperial College London and in CNWL Mental Health NHS Foundation Trust. David conducts psychopharmacological research, using brain-imaging techniques such as PET and MRI. He was trained in PET imaging at Columbia University in New York and later undertook a PhD at University Hospital Rigshospitalet in Copenhagen. Since 2009 he has been involved in imaging research in the neurobiology of addictions and major depression at Imperial. As Clinical Director and Deputy Head in the Centre for Psychedelic Research, he investigates mechanisms and therapeutic potential of MDMA, ketamine and classic psychedelics [trials in depression, OCD, anorexia nervosa, chronic pain], and in early 2021 David set up a new NHS-based psychopharmacology & psychedelic research Clinic at St Charles Hospital in London, named the CIPPRes Clinic.